Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 11, 2000, Pages 2379-2385

  Emanueli, Costanza ^a,b   Zacheo, Antonella ^a   Minasi, Alessandra ^a   Chao, Julie ^d   Chao, Lee ^d   Salis, Maria Bonaria ^a,b   Stacca, Tiziana ^b   Straino, Stefania ^a   Capogrossi, Maurizio C ^a   Madeddu, Paolo ^a,b,c  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiogenesis; Gene delivery; Kallikrein; Kinins; Nitric oxide

Indexed keywords

ANGIOGENIC FACTOR; CYCLOOXYGENASE 2; KININ; NIMESULIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TISSUE KALLIKREIN;

ADENOVIRUS; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; KALLIKREIN KININ SYSTEM; MOUSE; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE; TRANSGENE;

EID: 0033758642     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.11.2379     Document Type: Article

References (50)

1. Bioregulation of kinins: Kallikreins, kininogens, and kininases
2. Pharmacology of bradykinin and related kinins
3. 1 receptors as a new inflammatory target: Could this B the 1
4. 2 receptor from human fibroblast
5. Endothelium and control of vascular function: State of the art lecture
6. Local hormonal factors (intracrine, autocrine and paracrine) in hypertension
7. Regulation of mitogenesis by kinins in arterial smooth muscle cells
8. 2-receptor gene
9. 2 receptor knockout mice
10. Targeted disruption of the tissue kallikrein gene triggers cardiac abnormalities typical of a dilated cardiomyopathy
11. 1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effect
12. 9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats
13. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
14. 2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats
15. 165 as sole therapy for myocardial ischemia
16. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
17. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct myocardial administration of an adenovirus vector expressing the VEGF121 cDNA
18. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
19. 165
20. Coronary collateral development: Concepts and hypotheses
21. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
22. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor
23. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor
24. 121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
25. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart
26. The natural history of peripheral vascular disease: Implications for its management
27. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats
28. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats
29. Gene therapy in hypertension: Adenovirus-mediated kallikrein gene delivery in hypertensive rats
30. 2 receptors in the mouse
31. Indomethacin induced gastropathy in CD18, intercellular adhesion molecule 1, or P-selectin deficient mice
32. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation
33. Animal model: Mouse model of angiogenesis
34. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
35. Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats
36. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
37. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model
38. Angiogenic growth factor and revascularization of the ischemic limb: Evaluation in a rabbit model
39. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
40. Activation of the 92 kDa type IV collagenase by tissue kallikrein
41. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
42. 2) receptors on synovial fluid neutrophils in rheumatoid arthritis
43. Assembly of contact-phase factors on the surface of the human neutrophil membrane
44. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty
45. Role of endothelial kinins in control of coronary nitric oxide production
46. 1 and copper in angiogenesis
47. Pharmacology of prostaglandin endoperoxide synthase isoenzyme-1 and -2
48. The coronary endothelium: A target for vascular endothelial growth factor: Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo
49. Vascular permeability of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle
50. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointima hyperplasia